Information  X 
Enter a valid email address

Victrex PLC (VCT)

  Print          Annual reports

Thursday 18 November, 2021

Victrex PLC

Director Declaration

RNS Number : 8649S
Victrex PLC
18 November 2021
 

 

18 November 2021  

 

Victrex plc - Director declaration

Victrex plc is an innovative world leader in high performance polymer solutions, delivering sustainable products which support CO2 reduction and bring environmental and societal benefit in multiple end-markets. The Group today announces it has been notified that Brendan Connolly, Non-Executive Director of Victrex, has been appointed as an independent director to the Board of Applus Services, S.A. ('Applus') with effect from 17 November 2021, as well as becoming a member of its Environment, Social and Governance Committee and the Appointments and Compensations Committee.  The appointment is subject to ratification at the next ordinary general shareholder meeting of Applus.

This announcement is made pursuant to paragraph 9.6.14 R of the Listing Rules.

 

 

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations & Corporate Communications 

+44 (0) 1253 898121 / +44 (0) 7809 595831

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of automotive, aerospace, energy & industrial, electronics and medical. Every day, millions of people use products and applications which contain our materials - from smartphones, aeroplanes and cars to oil and gas operations and medical devices. With over 40 years' experience, we develop world leading solutions in PEEK and PAEK based polymers, semi-finished and finished parts which shape future performance for our customers and our markets, bring environmental and societal benefits, and drive value for our shareholders. Find out more at  www.victrexplc.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNUWASRARUAAAA

a d v e r t i s e m e n t